Ontology highlight
ABSTRACT: Background
Alzheimer's disease (AD) is a major healthcare challenge, with existing diagnostics being costly/infeasible. This study explores retinal biomarkers from optical coherence tomography (OCT) and OCT angiography (OCTA) as a cost-effective and non-invasive solution to differentiate AD, mild cognitive impairment (MCI), and healthy controls (HCs).Methods
Participants from the CALLIOPE Research Program were classified as "Dem" (AD and early AD), "MCI," and "HCs" using neuropsychological tests and clinical diagnosis by a neurologist. OCT/OCTA examinations were conducted using the RTVue XR 100 Avanti SD-OCT system (VISIONIX), with retinal parameters extracted. Statistical analysis included normality and homogeneity of variance (HOV) tests to select ANOVA methods. Post-hoc
SUBMITTER: Ibrahim Y
PROVIDER: S-EPMC11906703 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature